KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Moderna (MRNA) over the last 7 years, with Q3 2025 value amounting to 0.33%.

  • Moderna's Return on Capital Employed fell 1300.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.28% for FY2024, which is 600.0% down from last year.
  • Per Moderna's latest filing, its Return on Capital Employed stood at 0.33% for Q3 2025, which was down 1300.0% from 0.3% recorded in Q2 2025.
  • Over the past 5 years, Moderna's Return on Capital Employed peaked at 0.97% during Q4 2021, and registered a low of 0.34% during Q1 2024.
  • Its 5-year average for Return on Capital Employed is 0.18%, with a median of 0.03% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 14500bps in 2021, then tumbled by -8500bps in 2023.
  • Moderna's Return on Capital Employed (Quarter) stood at 0.97% in 2021, then plummeted by -54bps to 0.45% in 2022, then tumbled by -159bps to 0.27% in 2023, then dropped by -16bps to 0.31% in 2024, then fell by -8bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.3% for Q2 2025, and 0.32% during Q1 2025.